02/26/2024
7:18 AM | Celldex Therapeutics (Filer)
| Form 424B5 | |
02/26/2024
6:05 AM | Celldex Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2024
6:01 AM | Celldex Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
11:52 AM | Celldex Therapeutics (Subject)
Kynam Capital Management, LP (Filed by)
| Form SC 13G | |
02/14/2024
10:48 AM | Celldex Therapeutics (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
02/14/2024
6:38 AM | Celldex Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/13/2024
8:41 AM | Celldex Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G | |
|
02/09/2024
7:50 AM | Celldex Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/04/2024
3:05 PM | Celldex Therapeutics (Issuer)
Martin Samuel Bates (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:15 PM | Celldex Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
11/08/2023
4:03 PM | Celldex Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
8:00 AM | Celldex Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:05 PM | Celldex Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/20/2023
3:15 PM | Cavanaugh Sarah (Reporting)
Celldex Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:16 PM | Celldex Therapeutics (Issuer)
Crowley Elizabeth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:16 PM | Celldex Therapeutics (Issuer)
Heath-Chiozzi Margo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:17 PM | Celldex Therapeutics (Issuer)
Jimenez Freddy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:17 PM | Celldex Therapeutics (Issuer)
Martin Samuel Bates (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:18 PM | Celldex Therapeutics (Issuer)
PEPIN RONALD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:19 PM | Celldex Therapeutics (Issuer)
Wright Richard M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:21 PM | Celldex Therapeutics (Issuer)
Young Diane C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:07 PM | Celldex Therapeutics (Issuer)
Shoos Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:07 PM | Celldex Therapeutics (Issuer)
Cohen Cheryl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:08 PM | Celldex Therapeutics (Issuer)
CONRAD HERBERT J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:09 PM | Celldex Therapeutics (Issuer)
MARINO JAMES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:10 PM | Celldex Therapeutics (Issuer)
NEIL GARRY ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:10 PM | Celldex Therapeutics (Issuer)
PENNER HARRY JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:11 PM | Brownlie Keith L (Reporting)
Celldex Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
7:54 AM | Celldex Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
04/25/2023
7:01 AM | Celldex Therapeutics (Filer)
| Form DEF 14A | |
